Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology

Acute Myelogenous Leukemia (AML) Clinical Trials

A listing of Acute Myelogenous Leukemia (AML) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Age:

Gender:

Location:

Display New/Updated only

 

First 1 2 3 4 Last 

California

University of California San Francisco Fresno Campus
Fresno California 93701

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

UCLA
Los Angeles California 90095-6956

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Sharp Memorial Hospital
San Diego California 92123

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Stanford Cancer Center
Stanford California 94305-582

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Innovative Clinical Research Institute
Whittier California 90603

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Colorado

Rocky Mountain Cancer Center
Denver Colorado 80218-1210

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Connecticut

The Hospital of Central Connecticut
Southington Connecticut 6489

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Florida

University of Florida Health Cancer Center at Orlando Health
Orlando Florida 32806

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Georgia

Memorial University Medical Center
Savannah Georgia 31404

AAML1031, A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND# 58443) and Sorafenib (IND# 69896) for Patients with High Allelic Ratio FLT3/ITD

View More ▼

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Omacetaxine to evaluate Acute Myelogenous Leukemia (AML)

Illinois

Northwestern University Medical Center Division of Hematology/Oncology
Chicago Illinois 60611

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Cancer Care and Hematology Specialists of Chicagoland, P.C. - Niles, IL
Niles Illinois 60714

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Indiana

Indiana University Cancer Center
Indianapolis Indiana 46202-528

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

View More ▼

Indianapolis Indiana 46237

A clinical research study of CDX-301 with or without plerixafor

Kansas

Kansas University Medical Center
Westwood Kansas 66205

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Louisiana

Ochsner Clinic Foundation
New Orleans Louisiana 70121-2483

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Massachusetts

Beth Israel Deaconess Medical Center
Boston Massachusetts 2215

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

University of Massachusetts
Worcester Massachusetts 1655

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Minnesota

Mayo Clinic
Rochester Minnesota 55905

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Missouri

Kansas City VA Medical Center/University of Kansas Medical Center
Kansas City Missouri 64128

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Washington University School of Medicine
St. Louis Missouri 63110

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

New Jersey

John Theruer Cancer Center at Hackensack University Medical Center
Hackensack New Jersey 7601

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Cancer Institute of New Jersey
New Brunswick New Jersey 8901

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

New York

Winthrop University Hospital
Mineola New York 11501-3893

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Mt. Sinai Medical Center
New York New York 10029

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Columbia University Medical Center
New York New York 10032

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Weill Cornell Medical College
New York New York 10065

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

University of Rochester Medical Center
Rochester New York 14642

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

New York Medical College
Valhalla New York 10595

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

North Carolina

Duke University Medical Center
Durham North Carolina 27705

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Wake Forest University Health Sciences
Winston-Salem North Carolina 27157

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Ohio

University Hospitals Case Medical Center
Cleveland Ohio 44106

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

View More ▼

Columbus Ohio 43210

A clinical research study of CDX-301 with or without plerixafor

Pennsylvania

UPMC Cancer Pavillion
Pittsburgh Pennsylvania 70121-2483

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

South Carolina

Cancer Center of the Carolinas
Greenville South Carolina 29605

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Tennessee

Vanderbilt University Medical Center
Nashville Tennessee 37232-5505

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Tennessee Oncology
Nashville Tennessee 37203

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Texas

University of Texas Southwestern Medical Center
Dallas Texas 75390-9068

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Brooke-Army Medical Center
Fort Sam Houston Texas 78234

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

MD Anderson Cancer Center
Houston Texas 77030

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Methodist Hospital
San Antonio Texas 78229

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Cancer Care Centers of South Texas - Loop
San Antonio Texas 78217

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Virginia

VA Commonwealth University Massey Cancer Center
Richmond Virginia 23298-0037

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

View More ▼

Richmond Virginia 23298

A clinical research study of CDX-301 with or without plerixafor

Washington

Swedish Cancer Inst
Seattle Washington 98104

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Yakima Valley Memorial Hospital/ North Star Lodge
Yakima Washington 98902

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Wisconsin

Froedtert Hospital/BMT Medical College of Wisconsin
Milwaukee Wisconsin 53226-3522

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Australia

Royal Adelaide Hospital
Adelaide International SA 5000

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Austin Hospital
Heidelberg International 3084

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

Royal Hobart Hospital
Hobart International 7000

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to compare efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenance therapy in subjects with acute myeloid leukemia in complete remission

First 1 2 3 4 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.